Prior flu exposure dictates your future immunity, allowing for new, rationally developed regiments

A team of scientists, led by researchers at The Wistar Institute, has determined that it might be possible to stimulate the immune system against multiple strains of influenza virus by sequentially vaccinating individuals with distinct influenza strains isolated over the last century.

Their results also suggest that world health experts might need to re-evaluate standard tests used for surveillance of novel strains. Their findings are published in the Journal of Experimental Medicine, available online now.

According to the Wistar researchers, their analysis could lead to an alternative approach to creating a "universal" —a vaccine that would provide resistance to seasonal and strains over many years, negating the need for an annual .

"Influenza vaccines are very safe and provide good protection. However, we need to continuously update seasonal flu vaccines because influenza change over time," said Scott Hensley, Ph.D., an assistant professor at The Wistar Institute and corresponding author on the study. "Since are constantly changing, we all have unique pre-exposure histories that depend on when we were born and the specific types of viruses that circulated during our childhood."

Vaccines work by stimulating the immune system to produce antibody proteins against particles (called antigens) from an infectious agent, such as bacteria or a virus. The immune system saves the cells that produce effective antibodies, which then provide immunity against future attacks by the same or similar . Despite the availability of a vaccine, seasonal influenza typically kills 36,000 Americans, alone, and nearly a half million individuals around the world, in total.

Most current efforts to create universal vaccines hinge on the idea of generating antibodies against a portion of the virus that is relatively unchanged year-to-year.

"Our studies demonstrate that individuals that are infected sequentially with dramatically different influenza strains mount antibody responses against a conserved region of ," Hensley said. "Since we now know that pre-exposure events can influence vaccine responsiveness in a predictable way, we can begin to design vaccine regiments that preferentially elicit antibody responses against conserved regions of influenza virus."

The researchers began their current work by studying human antibody responses against the 2009 pandemic H1N1 virus. The 2009 strain is antigenically distinct from recently circulating seasonal H1N1 strains, and a distant relative of the virus that caused the devastating "Spanish Flu" of the early 20th century. The most effective antibodies are those that bind to a particular portion (or "epitope") of hemagglutinin (HA), a protein produced by the influenza virus.

According to Hensley, however, their chief insight occurred when his team hit the "sort" button on a spreadsheet document, thereby arranging all samples by age of the donor. Different aged people, they found, mount vastly different antibody responses to pandemic H1N1, depending on whether or not they were exposed to a seasonal H1N1 years earlier. "We can now accurately predict how individuals will respond to the pandemic H1N1 strain based on the year that they were born," Hensley said.

Their investigation also suggests that ferrets with no prior influenza exposure might not be the most reliable predictor of human immune responses. Anti-sera—or blood containing antibodies—created in these "naïve" ferrets are commonly used for influenza surveillance. The researchers found that naïve ferrets mount a response to an epitope in a decidedly different portion of HA than do most humans, but subsequently infecting these ferrets with other historical influenza strains can shift the antibody response toward the epitope that human antibodies recognize. This shift might also be replicable in humans through multiple infections or vaccinations, the researchers believe.

According to Hensley, one strategy would be to sequentially vaccinate children with antigenically distinct viral strains. "Babies are born with an immunological blank slate," Hensley said. "We may be able to strategically vaccinate our children with antigenically diverse to elicit antibodies against conserved viral epitopes."

add to favorites email to friend print save as pdf

Related Stories

Why do some influenza virus subtypes die out?

Nov 14, 2011

Every so often we hear about a new strain of influenza virus which has appeared and in some cases may sweep across the globe in a pandemic, much as the H1N1 virus did last year. What happens to the old seasonal viruses? In ...

Recommended for you

Could trophoblasts be the immune cells of pregnancy?

Dec 18, 2014

Trophoblasts, cells that form an outer layer around a fertilized egg and develop into the major part of the placenta, have now been shown to respond to inflammatory danger signals, researchers from Norwegian University of ...

Moms of food-allergic kids need dietician's support

Dec 18, 2014

Discovering your child has a severe food allergy can be a terrible shock. Even more stressful can be determining what foods your child can and cannot eat, and constructing a new diet which might eliminate entire categories ...

Multiple allergic reactions traced to single protein

Dec 17, 2014

Johns Hopkins and University of Alberta researchers have identified a single protein as the root of painful and dangerous allergic reactions to a range of medications and other substances. If a new drug can ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.